TriFoil Imaging is a leading player in the preclinical imaging industry, with its headquarters in Chatsworth, CA. Established in 2013, TriFoil Imaging is the result of the consolidation of Bioscan Inc. and Gamma Medica. The company delivers exceptional service for existing and older instruments, along with application-based assistance to clients globally, aiming to facilitate advancements in medicine and biology.
One of its flagship offerings, the InSyTe FLECT/CT, stands out as a preclinical optical imaging platform integrating the capabilities of fluorescence tomography and X-ray CT. Notably, the InSyTe FLECT/CT achieves 360° fluorescence and CT data acquisition, a pioneering feat in the industry, enabling authentic 3D tomographic imaging.
Despite the absence of publicly available data on its recent investment activities, TriFoil Imaging exhibits promise in revolutionizing preclinical imaging, with its cutting-edge technology and unwavering commitment to research and innovation.
There is no investment information
No recent news or press coverage available for TriFoil Imaging.